Artemis Clinical Research — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$4,550	1
2024	Research	$6,719	1
2023	Research	$14,095	1
2022	Research	$120,479	1
2021	Research	$19,714	1
2019	Research	$46,225	2

Breakdown

Who paid Research payments · program years 2019–2025

Novartis Pharmaceuticals Corporation $165,557 5 payments
E.R. Squibb & Sons, L.L.C. $46,225 2 payments

Studies the money was for Research payments · program years 2019–2025

A 5-Year, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Assessing the Efficacy, Safety, and Tolerability of Intra-Articular Regimens of Lna043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis $165,557 5 payments
A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with an Induction Period Followed by a Randomized Maintenance Period to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis $46,225 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.